Skip to main content
. Author manuscript; available in PMC: 2019 Aug 8.
Published in final edited form as: Hepatology. 2015 Jul 28;62(5):1346–1352. doi: 10.1002/hep.27938

Table 3.

Protective Effect of APOE Variants Against HEV Infection in Non-Hispanic Blacks* in the NHANES III, 1991–1994

Variant Allele Frequency (%) OR (95% CI) P

Non-Hispanic whites
APOE ε2   8.3 1 (reference)
APOE ε3 76.0 0.9 (0.7–1.2) 0.99
APOE ε4 15.7 0.9 (0.6–1.6) 0.99
Non-Hispanic blacks
APOE ε2 10.1 1 (reference)
APOE ε3 67.9 0.6 (0.4–0.8) 0.001
APOE ε4 22.0 0.5 (0.4–0.7) 0.00004
Mexican Americans
APOE ε2   3.3 1 (reference)
APOE ε3 85.7 0.9 (0.6–1.5) 0.99
APOE ε4 11.0 0.8 (0.5–1.6) 0.99
*

Logistic regression analysis within each race/ethnicity group.

Frequencies adjusted using NHANES III genetic sample weight.